BRAINLIFE Brain Tumor Medical Database

Gemcitabine

Home > Database > Treatment > Gemcitabine

Contents

Search


Brain Tumors


R. Goel, S. Gertler, D. J. Stewart, S. Laurie, G. Goss, N. Reaume, C. Cripps, D. Bedard, A. Rodgers, D. Cutler
Phase I study of temozolomide in conjunction with gemcitabine
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.2127 

Rakesh Goel, Stanley Gertler, David J Stewart, Scott Laurie, Glenwood Goss, Neil Reaume, Joanne Roach, Deborah Bedard, Angela Rodgers, David Cutler
Phase I study of temozolomide in conjunction with gemcitabine
ASCO Proceedings, 2002 Annual Meeting, Abstract No. 2162 



Germ Cell Tumors


J. Ikeda, H. Kobayashi, N. Ishii, Y. Sawamura, H. Aoyama, H. Shirato
Combination chemotherapy with gemcitabine and docetaxel for recurrent germ cell tumors in the central nervous system
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1540 


Glioblastoma


Fabi A, Mirri A, Felici A, Vidiri A, Pace A, Occhipinti E, Cognetti F, Arcangeli G, Iandolo B, Carosi MA, Metro G, Carapella CM.
Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study.
J Neurooncol. 2007 Nov 7; [Epub ahead of print]
Abstract

Sigmond J, Honeywell RJ, Postma TJ, Dirven CM, de Lange SM, van der Born K, Laan AC, Baayen JC, Van Groeningen CJ, Bergman AM, Giaccone G, Peters GJ.
Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer
Ann Oncol. 2008 Aug 12; [Epub ahead of print]
 Abstract

Wolfgang Wick, Mirjam Hermisson, Rolf D. Kortmann, Wilhelm M. Küker, Frank Duffner, Johannes Dichgans, Michael Bamberg, Michael Weller
Neoadjuvant Gemcitabine/treosulfan Chemotherapy for Newly Diagnosed Glioblastoma
Journal of Neuro-Oncology, 59 (2): 151-155, September 2002

 Abstract |  Reprint


Gliomas


Apparaju SK, Gudelsky GA, Desai PB. 
Pharmacokinetics of gemcitabine in tumor and non-tumor extracellular fluid of brain: an in vivo assessment in rats employing intracerebral microdialysis.
Cancer Chemother Pharmacol. 2007 Apr 19; [Epub ahead of print]
PMID: 17443325 [PubMed - as supplied by publisher]



Metastatic Tumors


Huang YJ, Wu YL, Xie SX, Yang JJ, Huang YS, Liao RQ. 
Weekly gemcitabine as a radiosensitiser for the treatment of brain metastases in patients with non-small cell lung cancer: phase I trial.
Chin Med J (Engl). 2007 Mar 20;120(6):458-62.
PMID: 17439736 [PubMed - in process]

D. Y. Kim, K. W. Lee, T. Yun, J. H. Kim, D. W. Kim, S. A. Im, T. Y. Kim, D. S. Heo, Y. J. Bang, N. K. Kim
Efficacy of platinum-based chemotherapy after cranial irradiation in patients with brain metastasis from non-small cell lung cancer
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No.1575 

J. Sgouros, S. Upadhyay, M. Braun, M. Holmes, A. Maraveyas
A phase I study of chemo-radiotherapy using gemcitabine as a radiosensitiser in patients with metastases to the brain
40th ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No. 1570 

 

This website is certified by Health On the Net Foundation. Click to verify. HOME ARCHIVES OF NEURO-ONCOLOGY CURRENT NEURO-ONCOLOGY NEWS CLINICAL NEURO-ONCOLOGY LIBRARY
DATABASE: Classification | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Management | Prognosis | Psychosocial Aspects | Stem Cells | Treatment
SERVICES
: About BrainLife | Children's Corner | E-mail Alerts | Journals | Links |
Motto, Dedication, etc. | Patients & Caregivers | Privacy Policy | Search | SiteMap bottom
This site complies with the HONcode standard for trustworthy health information: verify here